HeartBeam Inc. (NASDAQ: BEAT) has announced the launch of a pilot study focused on testing its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This study marks a significant step in the development of the HeartBeam patch, which has the potential to disrupt the $2 billion long-term continuous monitor and mobile cardiac telemetry (MCT) markets.
Coronary artery disease remains one of the most urgent and widespread health threats worldwide, contributing to millions of deaths each year and often progressing silently until a major cardiac event occurs. As healthcare providers search for faster and more accessible ways to identify high-risk patients earlier, HeartBeam's new pilot study aims to evaluate its technology's ability to detect inadequate blood flow and oxygen supply to tissue, known as ischemia.
"Ischemia detection has not been possible on patch-based ambulatory monitors, and they do not provide clinical-grade insights over an extended period of time," said HeartBeam CEO Robert Eno. "The HeartBeam patch is designed to change that. A device capable of generating an on-demand…"
The study represents a pivotal development for HeartBeam, as the patch could offer a non-invasive, convenient method for continuous cardiac monitoring that provides clinical-grade data. If successful, the technology could significantly improve early detection of coronary artery disease and ischemia, potentially reducing the number of silent cardiac events and improving patient outcomes.
The implications for the healthcare industry are substantial. Currently, patch-based ambulatory monitors are limited in their ability to detect ischemia, often requiring more invasive or less convenient methods for comprehensive cardiac assessment. HeartBeam's patch aims to fill this gap by providing on-demand 12-lead ECG capabilities, which are considered the gold standard for diagnosing cardiac conditions.
For investors, the success of this pilot study could position HeartBeam as a leader in the cardiac monitoring space, potentially capturing a significant share of the $2 billion market. The company's stock, traded under the ticker BEAT on NASDAQ, may see increased interest as developments unfold. More information about HeartBeam and its latest news can be found in the company’s newsroom at https://nnw.fm/BEAT.
This announcement was disseminated by NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NetworkNewsWire is part of the Dynamic Brand Portfolio @IBN, which provides access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release services, social media distribution, and tailored corporate communications solutions. For more information, visit https://www.NetworkNewsWire.com.
